Workshop planned to analyze federal medical countermeasures policies

The Institute of Medicine of the National Academies has announced a new workshop that will examine federal policies and activities in relation to discovery through approval of medical countermeasures for biological, chemical, radiological and nuclear threats.

The workshop, which will be held this week, will explore potential opportunities in the field by evaluating other models and systems with similar goals of developing medical products with low commercial viability.

Presentations and discussions that will be worked on at the workshop will be beneficial to assisting federal officials to improve the efficiency and effectiveness of developing medical countermeasures against acts of terrorism.

Among the objectives for the meeting are the identification and discussion of strategies meant to optimize the federal public health emergency medical countermeasures enterprise and the exploration of resource needs and other supporting components needed for accomplishing countermeasure discovery, development, production and approval goals.

Other objectives include an examination of strategies to enhance early phase investments towards potential public health interventions and identification and discussion models for enhancing partnerships and establishing new ones between federal programs, innovators and other commercial marketplaces.

The workshop will also focus on how market forces impact the advanced development biodefense community and examine ways to further evolve regulatory oversight processes for public health emergency medical countermeasures.